Document is current
Any future updates will be listed below
-
Authors
Saizan, Autumn L.
Mora Hurtado, Arielle Carolina
Rodman, Jack
Elbuluk, Nada
- License Information
-
More Information
Article History
Received: 22 September 2024
Accepted: 29 April 2025
First Online: 6 November 2025
Declarations
:
: This study was determined exempt by the University of Southern California (USC) Institutional Review Board. IRB #UP-20-01249. All participants were informed of the research study, confidentiality of the data, and minimal risk associated with participation. Participants were informed that the survey was voluntary, anonymous, with no responses linked to any identifiable information. Written informed consent documents were not required according to the USC IRB guidelines for determination of exemption. The study was conducted in accordance with institutional guidelines, and the principles of the Belmont Report were followed.
: Not applicable.
: Dr. Elbuluk has served as a consultant, advisory board member, and/or speaker for Avita, Incyte, VisualDx, Beiersdorf, Unilever, Eli Lilly, Galderma, Pfizer, La Roche Posay, L’Oreal, McGraw Hill, Dior, Medscape, Abbvie, Takeda, Sanofi, Janssen, Canfield. She has received royalties from McGraw-Hill. She has stock options in VisualDx. The remaining authors have no disclosures to report.
